Thursday, 16 August 2018

Rising Usage of NGS to Spur Targeted DNA/RNA Sequencing Demand

According to a research report published by Grand View Research, Inc.; the global targeted DNA/RNA sequencing market is estimated to reach USD 15.9 billion by 2025. Targeted DNA/RNA sequencing improves sequencing depth by enabling assessment of particular coding regions within specific genes. Various research projects are using the technology to reduce overall cost and evaluate only relevant genes. Increasing number of such research projects along with rising awareness regarding benefits of the technology is projected to stoke the market growth. Growing inclination toward Next-Generation Sequencing (NSG) is also contributing toward market expansion.

Targeted DNA/RNA Sequencing Market

Increasing use of NGS-based methods in several genome projects along with growing investments in their advancements can trigger the growth of this market. For instance, Fusion Genomics is developing an assay, called OneTest PathoGenome, which uses a combination of DNA/RNA capture probes, universal sample prep, and NGS. The company claims to identify the genomes of over 1,400 known human pathogens. It can capture pathogen nucleic acids from several human biological samples such as nasal washes, blood, biopsies, and sputum, in addition to environmental specimens such as mud and air.

Growing popularity of gene testing is one of the primary factors stimulating the growth of the global targeted DNA/RNA sequencing market. Gene testing is expanding the pool of data, which is allowing physicians and researchers to further comprehend genetic susceptibility to certain diseases. Among the regional markets, North America will command a sizeable share in the global industry throughout the forecast period (from 2018 to 2025). Grants allotted from National Institutes of Health (NIH) to encourage targeted sequencing research and study in U.S. is supporting the region’s growth. Some of the prominent companies operating in the global market are F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; Illumina, Inc.; Thermo Fisher Scientific, Inc.; and Agilent Technologies.

In-Depth Research Report On Targeted DNA/RNA Sequencing Market:
https://www.grandviewresearch.com/industry-analysis/targeted-dna-rna-sequencing-market

No comments:

Post a Comment

Ophthalmic Ultrasound Devices Market - Global Forecasts to 2026 by Grand View Research, Inc.

19-Mar-2020: The global ophthalmic ultrasound devices market size is expected to reach USD 728.7 million by 2026, according to a new repo...